Teladoc Health Inc (NYSE:TDOC)
$ 9.81 0.58 (6.28%) Market Cap: 1.69 Bil Enterprise Value: 2.03 Bil PE Ratio: 0 PB Ratio: 1.12 GF Score: 54/100

Q4 2019 Teladoc Health Inc Earnings Call Transcript

Feb 26, 2020 / 09:30PM GMT
Release Date Price: $116.86 (-1.30%)
Operator

Welcome to Teladoc's Fourth Quarter 2019 Earnings Conference Call and Webcast. (Operator Instructions)

It is now my pleasure to turn the floor over to Patrick Feeley, Vice President of Investor Relations. You may begin.

Patrick Thomas Feeley
Teladoc Health, Inc. - VP of IR

Thank you, and good afternoon. Today, after the market closed, we issued a press release announcing our fourth quarter and full year 2019 financial results. This press release is available in the Investor Relations section of the teladochealth.com website.

On this call to discuss the results are Jason Gorevic, our Chief Executive Officer; and Mala Murthy, our Chief Financial Officer.

During this call, we will also provide our first quarter and full year 2020 outlook, and our prepared remarks will be followed by a question-and-answer session. Please note that we will be discussing certain non-GAAP financial measures that we believe are important in evaluating Teladoc Health's performance. Details on the relationship between these non-GAAP measures to the most

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot